Katherine Singson New CEO of Volpara Solutions

Katherine Singson has been hired as the new CEO of Volpara Solutions.

Katherine Singson role will be to drive continued growth for Volpara’s breast cancer detection and patient tracking software. With 30+ years of experience from start-ups to multinationals including NeXT/Apple®, Pixar® and Microsoft®, Katherine brings both business-to-business as well as direct-to-consumer experience to this crucial new role.

After being mentored by Steve Jobs at all three of his companies, she spent several years abroad including in Sydney, Australia.  A highlight of this time overseas was working at Microsoft ANZ (Australia & New Zealand) where she partnered with Oprah Winfrey’s Ultimate Australian Adventure* to showcase both Windows and Xbox in a deeply humanistic manner.  Katherine is also a recent breast cancer survivor.

Volpara combines artificial intelligence, physics and data to measure breast density for early detection of cancer as well as the clinical management of images. Nearly half of women in the US have dense breast tissue.  Objective breast density analysis can help clinicians and their patients create a plan for ongoing screening based on each woman’s individual risk factors.  Additionally, Volpara’s software provides quality control for mammography centers and patient tracking software.

“As a purpose-driven technology company with the potential to transform the future of breast cancer, we’re excited to have someone of Katherine’s experience unleash our potential,” said Dr. Ralph Highnam, Founder and New Zealand-based Group CEO. “Volpara is already working with luminary customers across the US, including renowned sites in New York, Houston, San Francisco, Austin, Charlotte and Seattle, and of course, we want to reach many more. We look forward to Katherine positively impacting the healthcare industry and seeing how she’ll no doubt tap into the power and passion of women to obliterate advanced-stage breast cancer.”

“In these uncertain times, we aim to create a nimble, responsive and tastefully relentless approach to addressing this destructive disease,” said Katherine. “Since Covid-19, the idea of actively participating in one’s own self-care in partnership with leading-edge healthcare providers is stronger than ever.”

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.